Based on observations that Dmp1 null mice show osteomalacia accompanied by hypophosphatemia and elevated FGF-23 levels, this study set out to further characterize the skeletal abnormalities in Dmp1 null mice and determine the mechanisms responsible for those defects. This evidence concerns the gene FGF23 and osteomalacia.